Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer

Name: Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer
Published: 2002
License: Public Domain

GBG Forschungs GmbH · 2002

ClinicalTrials.gov · Datasets · License: Public Domain · 2002

Open Source ↗

breast-cancer

breast cancer, neoadjuvant therapy, pcr rates, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer

Related documents